Finance

Lists
Why is RYTM up 4.70%?
Dive Deeper
RYTM:NASDAQ
Rhythm Pharmaceuticals Inc
$115.02
+4.70%
(+5.16) 1D
$116.40
+1.20% (+1.38)
After hours
Closed: Nov 13, 4:00:00 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for RYTM...
Open
$109.81
High
$117.84
Low
$107.86
Mkt. cap
7.97B
Avg. vol.
1.45M
Volume
1.16M
52-wk high
$122.20
52-wk low
$74.50
EPS
-$2.91
Beta
2.17
Shares outstanding
69.33M
No. of employees
414
Open
$109.81
High
$117.84
Low
$107.86
Mkt. cap
7.97B
Avg. vol.
1.45M
Volume
1.16M
52-wk high
$122.20
52-wk low
$74.50
EPS
-$2.91
Beta
2.17
Shares outstanding
69.33M
No. of employees
414
News stories
From web sources and news partners
About Rhythm Pharmaceuticals Inc
CEO-
Employees414
FoundedNov 2008
HeadquartersBoston, Massachusetts, United States
SectorHealth Care
IndustryBiotechnology
Analyst ratings
Based on 15 analysts giving stock ratings to RYTM in the past 3 months
Strong buy
Buy
14
Hold
1
Sell
0
12-month forecast
Based on 15 Wall Street analysts offering 12 month price targets for RYTM in the last 3 months.
Highest
Current $115.02
$206.00 (+79.10%)
Average
$149.64 (+30.10%)
Lowest
$120.00 (+4.33%)
Analyst
Recommendation
Action
Price target
Projected
Date
Priyanka Grover
J.P. Morgan
Buy
Maintained
$142.00
+23.5%
11/06/2026
Whitney Ijem
Canaccord Genuity
Buy
Maintained
$168.00
+46.1%
11/05/2026
Seamus Fernandez
Guggenheim
Buy
Reiterated
$147.00
+27.8%
11/04/2026
Samantha Semenkow
Citi
Buy
Reiterated
$143.00
+24.3%
11/05/2026
Derek Archila
Wells Fargo
Buy
Reiterated
$155.00
+34.8%
11/04/2026
Michael Ulz
Morgan Stanley
Buy
Maintained
$146.00
+26.9%
11/04/2026
Lisa Walter
RBC Capital
Buy
Reiterated
$159.00
+38.2%
11/03/2026
Jonathan Wolleben
Citizens JMP
Buy
Maintained
$166.00
+44.3%
11/04/2026
Tazeen Ahmad
Bank of America Securities
Buy
Reiterated
$150.00
+30.4%
11/03/2026
Phil Nadeau
TD Cowen
Buy
Maintained
$130.00
+13%
11/03/2026
Unknown Analyst
William Blair
Buy
Initiated
$206.00
+79.1%
10/15/2026
Alethia Young
William Blair
Buy
Initiated
$206.00
+79.1%
10/15/2026
Sharon Zackfia
William Blair
Buy
Initiated
$206.00
+79.1%
10/15/2026
Ram Selvaraju
H.C. Wainwright
Buy
Reiterated
$130.00
+13%
10/12/2026
Kalpit Patel
Wolfe Research
Buy
Initiated
-
-
09/17/2026
Jim Kelly
Leerink Partners
Buy
Initiated
$133.00
+15.6%
09/14/2026
Basma Radwan
Leerink Partners
Buy
Initiated
$133.00
+15.6%
09/14/2026
Unknown Analyst
Leerink Partners
Buy
Initiated
$133.00
+15.6%
09/14/2026
David Hoang
Deutsche Bank
Hold
Initiated
$120.00
+4.3%
08/27/2026
Joseph Stringer
Needham
Buy
Maintained
$130.00
+13%
08/04/2026
Unknown Analyst
J.P. Morgan
Buy
Initiated
$145.00
+26.1%
07/27/2026
Dennis Ding
Jefferies
Buy
Maintained
$125.00
+8.7%
06/15/2026
Corinne Johnson
Goldman Sachs
Buy
Maintained
$159.00
+38.2%
06/14/2026
Paul Matteis
Stifel Nicolaus
Buy
Reiterated
$133.00
+15.6%
06/15/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
57.25M
60.11M
71.26M
92.13M
Cost of goods sold
4.80M
7.16M
8.93M
12.17M
Cost of revenue
4.80M
7.16M
8.93M
12.17M
Research and development expenses
42.03M
41.72M
43.43M
52.48M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
57.48M
63.59M
67.45M
66.75M
Operating expense
99.51M
105.32M
110.88M
119.23M
Total operating expenses
104.32M
112.47M
119.81M
131.40M
Operating income
-47.06M
-52.36M
-48.55M
-39.27M
Other non operating income
57.00K
-3.10M
1.02M
-157.00K
EBT including unusual items
-47.54M
-55.09M
-48.85M
-40.76M
EBT excluding unusual items
-47.54M
-55.09M
-48.85M
-40.76M
Income tax expense
-31.00K
545.00K
444.00K
610.00K
Effective tax rate
0.07%
-0.99%
-0.91%
-1.50%
Other operating expenses
-
-
-
-
Net income
-47.50M
-55.64M
-49.30M
-41.37M
Net profit margin
-82.97%
-92.56%
-69.19%
-44.90%
Earnings per share
-0.73
-0.83
-0.73
-0.61
Interest and investment income
4.08M
3.55M
3.22M
3.16M
Interest expense
-4.62M
-4.58M
-4.54M
-4.50M
Net interest expenses
-530.00K
-1.03M
-1.32M
-1.33M
Depreciation and amortization charges
-
-
-
-
EBITDA
-46.79M
-52.11M
-48.30M
-39.02M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google apps